Nicotinic acetylcholine receptors (nAChRs) are the molecular target of nicotine. nAChRs in the medial habenula (MHb) have recently been shown to play a role in nicotine dependence, but it is not clear which nAChR subtypes or MHb neuron types are most important. To identify MHb nAChRs and/or cell types that play a role in nicotine dependence, we studied these receptors and cells with brain slice electrophysiology using both acute and chronic nicotine application. Cells in the ventroinferior (MHbVI) and ventrolateral MHb (MHbVL) subregions expressed functional nAChRs with different pharmacology. Further, application of nicotine to cells in these subregions led to different action potential firing patterns. The latter result was correlated with a differing ability of nicotine to induce nAChR desensitization. Chronic nicotine caused functional upregulation of nAChRs selectively in MHbVI cells, but did not change nAChR function in MHbVL. Importantly, firing responses were also differentially altered in these subregions following chronic nicotine. MHbVI neurons treated chronically with nicotine exhibited enhanced basal pacemaker firing but a blunted nicotine-induced firing response. MHbVL neurons did not change their firing properties in response to chronic nicotine. Together, these results suggest that acute and chronic nicotine differentially affect nAChR function and output of cells in MHb subregions. Because the MHb extensively innervates the interpeduncular nucleus, an area critical for both affective and somatic signs of withdrawal, these results could reflect some of the neurophysiological changes thought to occur in the MHb to the interpeduncular nucleus circuit in human smokers.
Introduction
Chronic exposure to nicotine in tobacco products results in numerous health consequences (lung cancer, emphysema, hypertension, etc.) and accounts for over 6 million deaths per year (World Health Organization, 2011) . Nicotine is the primary psychoactive substance in tobacco products, and it is addictive due to its ability to strongly activate neuronal nicotinic acetylcholine receptors (nAChRs) (Steinsland and Furchgott, 1975) . It has recently been appreciated that longterm nicotine use is maintained via a balanced activation of brain circuits mediating both positive (rewarding) and negative (aversive) motivational signals Hikosaka, 2007, 2009; Bromberg-Martin et al., 2010; Hikosaka, 2010) . It is also established that chronically exposing the brain to nicotine changes nAChR number and/or function in key brain circuits (Marks et al., 1983; Lester et al., 2009) . These alterations in nAChR function and the consequent changes in neuronal circuit activity where these receptors reside are among the key events important for establishing and maintaining addiction to nicotine. Positive motivational signals generated by nicotine use the mesolimbic dopamine pathway, and much has been learned regarding this system (Laviolette and van der Kooy, 2004; Dani and Harris, 2005; Dani and Bertrand, 2007) . By contrast, relatively little is known about the nAChRs and brain circuits mediating nicotine's aversive quality. In this study, we sought to study one of the key brain areas mediating negative motivational signals after nicotine use: the medial habenula (MHb).
The MHb is a small bilateral structure immediately ventral to the hippocampus and adjacent to the third ventricle. The MHb sends a prominent projection via the fasciculus retroflexus to a midline structure in the ventral midbrain: the interpeduncular nucleus (IPN). Via the MHb's connection to areas such as the septum and nucleus of diagonal band (Herkenham and Nauta, 1977; Qin and Luo, 2009 ) and the IPN's connection to the raphe (Shibata and Suzuki, 1984; Montone et al., 1988) , the MHb to IPN pathway is a key circuit connecting forebrain structures with midbrain areas important for motivation and reward. The MHb to IPN pathway is a crucial mediator of nicotine withdrawal following chronic exposure to nicotine, and specific nAChRs play a key role.
For example, mice lacking a5 and b4 subunits, which are expressed in the MHb or IPN, exhibit reduced withdrawal responses when chronic nicotine is removed (Salas et al., 2004 . Similarly, antagonizing nAChRs via infusion of pharmacological blockers into the MHb also reduces the severity of nicotine withdrawal ). Mice lacking a5 subunits self-administer greater amounts of nicotine (i.e., they have reduced aversive signals at high doses of nicotine), and self-administration is normalized when a5 subunits are reintroduced into the MHb (Fowler et al., 2011) . Conversely, transgenic mice overexpressing nAChRs in MHb show enhanced sensitivity to the aversive aspects of nicotine (Frahm et al., 2011) .
Although these early and seminal studies clearly demonstrate the importance of MHb nAChRs in the motivational response to nicotine, a detailed picture elucidating specific nAChRs in specific MHb neurons has not yet emerged. Both classic and recent studies have determined that the MHb is not a homogeneous structure, but is rather a collection of diverse cell types that could have varied physiologic actions. For example, several MHb subnuclei exist that each contain neuron types expressing various biochemical markers (Aizawa et al., 2012) . Cells in the dorsal 1/3 of the MHb preferentially express substance P, whereas cells in the ventral 2/3 of the MHb preferentially express choline acetyltransferase (ChAT), a cholinergic marker (Contestabile et al., 1987; Yamaguchi et al., 2013) . The dorsal and ventral MHb project to anatomically divergent components of the IPN (Contestabile and Flumerfelt, 1981; Yamaguchi et al., 2013; Shih et al., 2014) , and different regions of IPN have recently been appreciated to mediate diverse aspects of nicotine withdrawal. For example, the dorsal IPN, which receives projections from the ventrolateral MHb (MHbVL), is a key mediator of the somatic aspect of nicotine withdrawal (ZhaoShea et al., 2013) . Further, areas in the ventral IPN, which receive projections preferentially from ventroinferior MHb (MHbVI), appear to more strongly control affective signs of nicotine withdrawal (Zhao-Shea et al., 2015) . These recent data point to the need for a more thorough description of the nAChRs in different subnuclei of MHb. In this study, we used brain slice patch clamp electrophysiology, pharmacology, and genetics to examine nAChR function in MHbVI and MHbVL. We present evidence demonstrating that nAChRs in different MHb subregions respond differently to acute and chronic nicotine, which in turn differentially affect neuronal activity in these areas.
Materials and Methods
Animals. All procedures involving the use of live animals conformed to the guidelines provided by the National Institutes of Health Office of Laboratory Animal Welfare. All protocols were approved by the Purdue University Institutional Animal Care and Use Committee. Mice were housed at 22°C, with an alternating 12-hour light/dark cycle. Food and water was available ad libitum. Mice were weaned and group housed with same sex littermates at postnatal day 21. Adult (2-3 months old) mice were used for this study. No gender-based differences were noted, so male and female data were pooled for subsequent analyses.
Most studies were conducted with C57BL/6 wild-type (WT) mice obtained from Jackson Laboratories (Bar Harbor, ME). Select experiments used genetically modified mice. a4 knockout (a4KO) mice were a generous gift of Drs. Michael Marks and Jerry Stitzel (University of Colorado, Boulder, CO) and were produced by mating mice heterozygous for the a4KO allele. a6L9S mice were generated as previously described (Drenan et al., 2008) . A Leu "9-prime" to Ser mutation was introduced into a bacterial artificial chromosome (BAC) at the a6 nAChR subunit gene. Mutant BAC DNA was injected into FVB/N embryos, and the embryos were implanted into pseudopregnant Swiss-Webster surrogates. The transgene insertion site in the mouse genome is unknown. Founder animals were identified and backcrossed to C57BL/6 mice for 12 or more generations. As a result, 90-95% of the genome of the a6L9S strain is expected to be C57BL/6. FVB/ N allelic DNA close to the insertion site is likely to persist. The L9S mutation leaves a6* nAChRs 10-to 100-fold more sensitive to ligands compared with non2a6* nAChRs (Drenan et al., 2008 (Drenan et al., , 2010 Cohen et al., 2012) . Previous studies have confirmed that a6* nAChRs are not overexpressed or expressed in ectopic brain regions in a6L9S mice (Drenan et al., 2008 (Drenan et al., , 2010 . Littermate mice not harboring the mutant BAC served as controls for a6L9S mice in electrophysiology experiments. Mutant mouse lines were genotyped by polymerase chain reaction analysis of isolated tail DNA as previously described (Drenan et al., 2008) .
Brain Slice Preparation. Mice were anesthetized with sodium pentobarbital (100 mg/kg i.p.) and transcardially perfused with 4°C Nmethyl-D-glucamine-based recovery solution (in mM: 93 N-methyl-Dglucamine, 2.5 KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 20 HEPES, 25 glucose, 5 Na-ascorbate, 2 thiourea, 3 Na-pyruvate, 10 MgSO 4 ×7H 2 O, and 0.5 CaCl 2 ×2H 2 O). Brains were removed and 200-mm-thick coronal slices containing the MHb were prepared with a vibrating microslicer (DTK Zero 1; Ted Pella, Redding, CA). Slices were allowed to recover for 12 minutes at 33°C and then at room temperature for 1-8 hours in HEPESholding solution (in mM: 92 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 20 HEPES, 25 glucose, 5 Na-ascorbate, 2 thiourea, 3 Na-pyruvate, 2 MgSO 4 ×7H 2 O, and 2 CaCl 2 ×2H 2 O). All solutions were saturated with 95% O 2 and 5% CO 2 , with osmolarity adjusted to 300-310 mOsm.
Patch Clamp Electrophysiology. Each individual slice was transferred to a recording chamber and was continuously superfused at a rate of 2-3 ml/min at 30-32°C (Warner Instrument, Hamden, CT), with standard recording artificial cerebrospinal fluid (in mM: 124 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 24 NaHCO 3 , 12.5 glucose, 2 MgSO 4 ×7H 2 O, and 2 CaCl 2 ×2H 2 O). MHb neurons were visually identified under infrared illumination using a Nikon FN-1 microscope equipped with differential interference contrast optics and a waterimmersion objective lens (40Â, numerical aperture 5 0.8; Nikon, Tokyo, Japan). MHb cell recordings were obtained from either the MHbVI area close to the third ventricle or the MHbVL area adjacent to the lateral habenula (Fig. 1A) . Whole-cell recordings and cell-attached recordings were obtained with patch pipettes filled with internal solution (in mM: 135 K-gluconate, 5 EGTA, 10 HEPES, 2 MgATP, 0,1 NaGTP, 0.5 CaCl 2 , and 2 MgCl 2 , pH adjusted to 7.3 with Tris base). In a subset of experiments, 2.5 mg/ml biocytin was added to the internal solution to mark the recorded neuron for later cytochemical characterization. Data were collected using a Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA), filtered at 2 kHz, and sampled at 10 kHz by a Digidata 1440A digitizer (Molecular Devices). Series resistance was measured by injection of hyperpolarizing pulses (25 mV, 100 milliseconds) and was not compensated. To examine the functional nAChR response, acetylcholine (ACh) was locally applied (250 milliseconds, 12 psi) at different concentrations (1-100 mM) using a glass pipette connected to a PV-820 Pneumatic Picopump (World Precision Instruments, Inc., Sarasota, FL). This pipette was moved to within 20-40 mm of the recorded cell with a piezoelectric manipulator (PA-100/12; Piezosystem Jena, Hopedale, MA) for drug application and retracted after the end of the puff to minimize nAChR desensitization. All other drugs were bath perfused at final concentrations indicated by diluting aliquots of stock solution in artificial cerebrospinal fluid.
Immunohistochemistry. To identify the location of recorded cells, slices containing biocytin-loaded cells were fixed by immersion in 4% paraformaldehyde in phosphate-buffered saline (PBS) overnight at 4°C. Sections were washed 2 times for 10 minutes per wash in PBS, blocked, and permeabilized for 60 minutes in PBS containing 10% normal horse serum, 2% bovine serum albumin, and 0.3% Triton X-100 (PBST). Primary antibody incubations were done overnight at 4°C in PBST containing goat anti-ChAT (1:500; Millipore, Billerica, MA) and streptavidin conjugated Alexa-488 (1:1000; Thermo Fisher, Waltham, MA). After three PBS washes, secondary antibody incubations were performed for 2 hours at room temperature in PBST containing Alexa-555 donkeyanti-goat (1:500; Invitrogen). Sections were finally washed 3 times for 10 minutes per wash, mounted with antifade mounting medium (Vectashield; Vector Laboratories, Burlingame, CA), and coverslipped for confocal microscopy.
Chronic Nicotine Treatment. Nicotine dependence was induced with osmotic minipumps (model 2004; Alzet, Cupertino, CA) as previously reported (Shih et al., 2014) . These minipumps, implanted subcutaneously under brief isoflurane anesthesia, were filled with either sterile saline or (-)-nicotine hydrogen-tartrate salt (Glentham Life Sciences, Corsham, UK) dissolved in sterile saline. Mice received a mean dose of 1 mg/kg per hour of nicotine for 14 days. The nicotine dose used in this study to develop physical dependence was chosen based on the results obtained in previous studies (Matta et al., 2007; Hilario et al., 2012; Shih et al., 2014) . This dose yields plasma levels of ∼0.3 mM, a concentration similar to that observed in human smokers consuming an average of 17 cigarettes a day (Matta et al., 2007) .
Data Analysis and Statistical Methods. Off-line data analysis was performed using Clampfit 10 (Molecular Devices), GraphPad Prism 6 (GraphPad Software, La Jolla, CA), and Origin 9.0 (Originlab, Northampton, MA). Summary data are reported as mean 6 S.E.M. Statistical significance was assessed by two-tailed paired t tests to assess the effect of a drug within a recorded neuron and unpaired t test to compare across neurons. One-way analysis of variance (ANOVA) followed by Tukey's post hoc tests was applied for multiple comparisons. Differences were considered statistically significant at p , 0.05.
Chemicals. All reagents were made from 1000Â stock solutions kept frozen at 220°C in 50-100 ml aliquots. 6-Cyano-7-nitroquinoxaline-2,3-dione was purchased from Tocris (Bristol, UK). a-Conotoxin MII was synthesized as described previously (Azam et al., 2010) . Unless specified otherwise, all other chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
Results
In our previous study, we developed a map of nAChR subunit expression and localization within MHb. We noted that the a4, a6, b2, and b3 subunits exhibit a localization gradient from inferior to lateral across the ventral portion of MHb. In particular, a4 subunits are concentrated in MHbVL and a6 subunits are preferentially confined to MHbVI (Shih et al., 2014) . Given that the patterns seen for various nAChR subunits suggest that specific subdivisions exist in MHb, we first sought to determine whether nAChRs in MHbVL and MHbVI exhibit functional differences. To compare the ACh sensitivity in MHbVL and MHbVI, we performed whole-cell patch recordings from visually identified cells in these two subregions. Our definition of MHbVI and MHbVL follows that of a recent study (Aizawa et al., 2012) . MHbVL cells are located in the lateral one-third of the ventral MHb, mostly along the border between MHb and the lateral habenula. MHbVI cells are located in the inferior one-third of the ventral MHb, adjacent to the third ventricle (Fig. 1A) . To further verify the location of recorded cells, a subset of cells was filled with biocytin during recordings, followed by post hoc identification using immunostaining and confocal microscopy. ChAT costaining was used to label the boundary of the ventral MHb ( Fig. 1B) (Contestabile et al., 1987) .
To study nAChR function, local pressure application was used to apply brief (250 millisecond) pulses of ACh from glass micropipettes positioned approximately 20-40 mm from the recorded cells using a piezoelectric translator as previously described (Engle et al., 2013) . A low concentration of ACh (1 mM) evoked small inward currents or a zero current at a holding potential of 260 mV (Fig. 1, C and D) , irrespective of the location of the cells (MHbVL: 9.1 6 3.1 pA, n 5 6; MHbVI: 7.5 6 3.4 pA, n 5 4, p 5 0.7460). Application of 100 mM ACh induced currents of similar peak amplitude in MHbVL and MHbVI neurons (Fig. 1 , C and D) (MHbVL: 489.0 6 118.8 pA, n 5 6; MHbVI: 597.9 6 172.9 pA, n 5 4, p 5 0.6310). These findings indicate that neurons in MHbVL and MHbVI have roughly equal sensitivity to puff-applied 1 and 100 mM ACh. MHb neurons are highly enriched in mRNAs for most nAChR subunits (Marks et al., 1992) .
Immunoprecipitation and immunopurification studies revealed a wealth of uncommon nAChR subtypes in MHb (Grady et al., 2009 ). The nAChRs expressed in MHb can be grouped to two major and distinct nAChR populations: b2-and b4-containing nAChRs (b2* and b4*; the asterisk indicates other unidentified subunits may coassemble with the indicated subunits). Next, we sought to determine which nAChR subtype(s) is/are responsible for the ACh-induced currents we measured in MHbVL and MHbVI. First, we tested whether ACh-induced currents in MHbVL and MHbVI could be blocked by the a3b4* nAChR antagonist SR16584 (20 mM). Application of SR16584 resulted in a significant blockade of AChinduced currents in both MHbVL (Fig. 1 , E and F; n 5 6, 44.9 6 8.1% remaining response, p 5 0.0223) and MHbVI areas (Fig. 1 , E and F; n 5 5, 51.0 6 7.4% remaining response, p 5 0.0141). Next, we tested dihydro-b-erythroidine (DHbE), which is traditionally used to discriminate b2* nAChRs from homomeric a7 nAChRs. We applied ACh (100 mM) with a puff electrode for 250 milliseconds and repeated this procedure after a 15-minute exposure to DHbE (500 nM). ACh-induced currents in MHbVL were not influenced by DHbE exposure (Fig. 1 , G and H; n 5 5, 108.0 6 10.2% remaining response, p 5 0.5568). In contrast, ACh-induced currents in MHbVI neurons were partially inhibited after application of DHbE (Fig. 1 , G and H; n 5 5, 78.7 6 2.9% remaining response, p 5 0.0196). These data show that pharmacologically distinct nAChRs exist in MHbVL and MHbVI.
Our previous studies strongly suggest that functional a6* nAChRs are expressed in MHbVI (Henderson et al., 2014; Shih et al., 2014) . We conducted further pharmacological experiments to test this hypothesis. a-Conotoxin MII (aCtxMII), a cone snail toxin, is an antagonist with selectivity for a6* and a3* nAChRs. In particular, aCtxMII is 5.6-fold more selective for a6* versus a3* nAChRs, with little activity at other nAChR subtypes (Cartier et al., 1996; McIntosh et al., 2004 ). We measured ACh (100 mM) evoked current amplitudes in MHbVL and MHbVI neurons before and after bath application of 100 nM aCtxMII. Interestingly, aCtxMII did not significantly affect responses to 100 mM ACh in either MHb subregion (Fig. 2, A and B ; MHbVL: 102.3 6 5.6% remaining response, n 5 4, p 5 0.8332; MHbVI: 108.7 6 14.2% remaining response, n 5 8, p 5 0.8793). a6* nAChRs in the dopamine pathway are known to exhibit high sensitivity to ACh and nicotine (Salminen et al., 2007) so we reasoned that if functional MHb a6* nAChRs exist, they may also exhibit high ACh sensitivity. We therefore tested the ability of aCtxMII to block currents evoked by lower concentrations of ACh, as the large currents evoked by 100 mM ACh (∼500 pA) could preclude us from effectively isolating a small, aCtxMIIsensitive response. In MHbVI neurons, 10 mM ACh reliably evoked inward currents of 50-75 pA ( Fig. 2C ; 63.0 6 13.1 pA, n 5 9). An aCtxMII bath application resulted in a significant inhibition of inward currents evoked by 10 mM ACh in seven of nine MHbVI cells tested (Fig. 2, C and D ; 51.6 6 4.7% remaining response, p 5 0.0085). In MHbVL neurons, 10 mM ACh was insufficient to evoke workable inward currents, but a 30 mM ACh application did result in measurable currents ( Fig.  2C ; 79.8 6 10.4 pA, n 5 5). However, aCtxMII was unable to block or attenuate inward currents evoked by 30 mM ACh in any of the MHbVL cells tested (Fig. 2, C and D ; 103.7 6 13.9% remaining response, p 5 0.8286). These results suggest that MHbVI neurons express a high-sensitivity nAChR subtype, with sensitivity to aCtxMII.
To further test the hypothesis that the aCtxMII-sensitive nAChR subtype we identified in MHbVI neurons contains a6 subunits, we studied functional nAChR responses in a6L9S mice. a6L9S mice are a transgenic mouse strain harboring a bacterial artificial chromosome that directs expression of an a6 nAChR subunit, with a Leu to Ser mutation at a conserved residue in the second transmembrane a-helix (Drenan et al., 2008) . This mutation renders a6* nAChRs "hypersensitive" to and after (gray trace; offset for clarity) application of aCtxMII (100 nM). Different ACh concentrations were used in MHbVL versus MHbVI based on the minimum ACh concentration that evoked workable inward currents. Scale bar: 50 pA, 500 milliseconds (MHbVL); 60 pA, 500 milliseconds (MHbVI). (D) Summary bar graphs to indicate the degree of inhibition by aCtxMII (i.e., the fraction of control current remaining after application of aCtxMII) for 30 mM (MHbVL) or 10 mM (MHbVI) AChevoked responses; *p , 0.05 (paired t test). (E) Representative traces for 1 mM ACh-evoked currents in MHbVL and MHbVI cells in slices from a6L9S mice. MHbVI cells, which responded robustly to 1 mM ACh (black trace), were subsequently exposed to aCtxMII (100 nM), and 1 mM AChevoked currents were measured in the presence of aCtxMII (gray trace). Scale bar: 70 pA, 500 milliseconds. (F) Summary bar graphs to indicate the average 1 mM ACh-evoked current response amplitude in MHbVL and MHbVI neurons in slices from a6L9S and nontransgenic control littermate (WT) mice; ***p , 0.001 (one-way ANOVA, Tukey's post hoc test).
agonists, such as nicotine and ACh. By puff applying low concentrations of ACh, a6* nAChRs can be selectively activated (Drenan et al., 2008; Engle et al., 2012 Engle et al., , 2013 Powers et al., 2013) . This is a helpful method for determining whether a particular cell type in the brain expresses functional a6* nAChRs. We therefore studied MHbVL and MHbVI neurons in a6L9S mice. Whereas MHbVL neurons did not respond appreciably to low (1 mM) concentrations of ACh (Fig. 2, E and  F ; 11.9 6 1.7 pA, n 5 7), MHbVI neurons in slices from a6L9S mice responded with robust inward currents following application of 1 mM ACh (Fig. 2, E and F ; 102.8 6 13.0 pA, n 5 8; ANOVA: F (4,25) 5 30.05, p , 0.0001; Tukey's post hoc test: p , 0.001 versus WT). Further, ACh (1 mM) evoked currents in a6L9S MHbVI neurons were substantially blocked by bath application of aCtxMII (Fig. 2, E and F ; 20.4 6 3.0% remaining response, n 5 5; Tukey's post hoc test: P , 0.001 versus a6L9S). These pharmacological data in C57BL/6 WT and a6L9S mice strongly support the hypothesis that MHbVI, but not MHbVL, neurons express functional, high-sensitivity a6* nAChRs.
MHb neurons fire spontaneous action potentials in slice preparation (Gorlich et al., 2013; Dao et al., 2014; Shih et al., 2014) . To examine the effects of short-term nicotine exposure on MHbVL and MHbVI neuron firing rates, we recorded baseline and nicotine-elicited action potential firing. Using the cell-attached mode in recordings from MHbVL and MHbVI neurons, firing was recorded before, during, and after a 16-minute bath exposure to nicotine (1 mM). Although typical nicotine concentrations in the cerebrospinal fluid of smokers is ∼300 nM, higher concentrations have been reported (Malkawi et al., 2009 ). Cell-attached recording was chosen to avoid disturbing the intracellular milieu. In addition, action potentials were recorded in the presence of a cocktail of inhibitors to block muscarinic receptors, type A gamma aminobutyric acid receptors, and glutamate receptors (1 mM atropine, 100 mM picrotoxin, and 10 mM 6-cyano-7-nitroquinoxaline-2,3-dione) to better isolate the actions of nAChRs. In three MHb neurons, the firing frequency at rest was not altered by these inhibitors (data not shown), suggesting that tonic action potential firing is driven by intrinsic factors and is independent of inputs releasing glutamate, gamma aminobutyric acid, or ACh. A recent study reached a similar conclusion regarding spontaneous firing in MHb neurons (Gorlich et al., 2013) .
Neurons from MHbVL and MHbVI fired at a similar frequency at rest (MHbVL, 5.5 6 0.6 Hz, n 5 9; MHbVI, 4.5 6 0.8 Hz, n 5 8, p 5 0.3366). MHbVL neurons increased their firing rate quickly in response to 1 mM nicotine, followed subsequently by attenuation of this increased firing in the continued presence of 1 mM nicotine (Fig. 3, A and B) . In MHbVI, the pattern was different. In response to 1 mM nicotine, firing increased slower than in VL neurons (Fig. 3,  A and B) . In contrast to the attenuated firing seen in VL neurons, VI neurons exhibited sustained firing in the continued presence of 1 mM nicotine for the duration of the experiment (Fig. 3, A and B) . We quantified action potential firing at three different time points during the experiment, and the results indicate a sustained increase for MHbVI cells at the end of the experiment ( Fig. 3C ; 8.2 6 0.6 Hz, p 5 0.0002 versus baseline). In contrast, in MHbVL cells the firing frequency was not different at the end of the experiment compared with the prenicotine firing rate ( Fig. 3C ; 6.1 6 0.9 Hz, p 5 0.5252 versus baseline). Together, these experiments reveal that nicotine has a differential ability to influence neuronal activity in MHbVL and MHbVI neurons. We next sought to determine whether nAChR desensitization accounted for these differences.
In experiments measuring action potential firing in ventral tegmental area (VTA) neurons, a biphasic response to nicotine was measured (Liu et al., 2012) . This response consists of an early and brief phase, followed by a later, sustained firing response that is hypothesized to be related to the desensitization properties of nAChR subtypes in VTA neurons (Liu et al., 2012) . We hypothesized that differences in nicotineelicited action potential firing in MHbVL and MHbVI was due to differential desensitization properties of nAChRs in these areas. To test this hypothesis, whole-cell recordings were made from MHbVL and MHbVI neurons in the voltage clamp mode. Inward cation currents through nAChRs were induced by pressure application of ACh (100 mM, 250 milliseconds) at 3-minute intervals to promote stable responses before nicotine application. Similar to a previous study (Pidoplichko et al., 1997) , we then tested the effect of a 15-minute nicotine (1 mM) application on the magnitude of these ACh-evoked currents. After 15 minutes of nicotine exposure, ACh puffs were resumed to determine whether there were any changes in current amplitude after nicotine exposure (Fig. 4A) . After 15 minutes of nicotine application, responses to ACh were Each experiment comprised a recording taken at 260 mV, and the firing rates were calculated at time point i (t = 2 minutes, baseline), ii (t = 8 minutes for MHbVL, t = 10 minutes for MHbVI, peak response in 1 mM nicotine), and iii (t = 18 minutes, prolonged exposure). (C) Quantification of summary data shown in (B). Average firing rates at the indicated time points are shown. **p , 0.01; ***p , 0.001 (paired t test).
Medial Habenula, Nicotine Dependence, and nAChRs reduced in MHbVL neurons (Fig. 4 , B and C, 449.5 6 79.1 and 286.7 6 66.5 pA before and after 15-minute nicotine exposure, respectively, n 5 9, p 5 0.0006). However, 1 mM nicotine did not desensitize ACh-induced currents in MHbVI neurons receiving the same 15-minute exposure (Fig. 4, D and E, 345.1 6 58.7 and 411.3 6 90.5 pA before and after 15-minute nicotine exposure, respectively, n 5 6, p 5 0.2396). In both sets of experiments, there was a significant increase in RMS current noise after 15-minute nicotine compared with baseline before drug perfusion (2.8 6 0.2 pA compared with 6.4 6 0.3 pA, p , 0.001), which is an indication of increased nAChR activity (Drenan et al., 2008) .
Desensitization is a common property of nAChRs, which are strongly influenced by subunit composition and stoichiometry.
In other brain areas, nAChRs containing a4 and b2 subunits desensitize within seconds to a few minutes of exposure to physiologically relevant concentrations of nicotine (Pidoplichko et al., 1997) . Receptors with a6 subunits appear to desensitize less than a4 (non-a6)* nAChRs . Previous studies have shown that neurons in the MHbVL express high levels of a4 receptors (Nashmi et al., 2007; Fonck et al., 2009; Shih et al., 2014) . Accordingly, we hypothesized that MHbVL nAChRs exhibit stronger desensitization due to the presence of a4 subunits. To investigate this, we performed the same desensitization experiment (Fig. 4A ) in a4KO mice. In MHbVL neurons from a4KO mice, AChinduced inward currents were not diminished by a nicotine (1 mM) bath application (Fig. 4, F and G, 237.2 6 26.0 and 234.2 6 31.4 pA before and after 15-minute nicotine exposure, respectively, n 5 7, p 5 0.8380). Consistent with our prior work (Shih et al., 2014) , peak currents were reduced in MHbVL neurons from a4KO mice relative to control mice (Fig. 4F) . These data suggest that due to their specific expression in MHbVL cells, a4* nAChRs mediate desensitization and attenuated action potential firing following exposure to smoking relevant concentrations of nicotine.
Our data indicate that acute nicotine causes differential activation of nAChRs and differential firing responses in MHbVL and MHbVI. Chronic nicotine treatment alters nicotinic cholinergic signaling in the MHb to IPN pathway (Salas et al., 2004 , and the acute mechanism we identified may play a role. To test our overall hypothesis that chronic exposure to nicotine differentially alters nAChR activity in subregions of MHb, we used a previously described protocol (Shih et al., 2014) . Mice were implanted (subcutaneously) with nicotine-filled minipumps for 14 days, which delivered nicotine at 1 mg/kg per hour in C57BL/6J mice; this dose generates plasma levels of nicotine ∼40 ng/ml (Sparks and Pauly, 1999) . This concentration is comparable with nicotine plasma levels measured in the afternoon in smokers (Matta et al., 2007 ) (10-50 ng/ml of nicotine or 60-310 nM of nicotine). Control mice were implanted with minipumps filled with saline. After 14 days of chronic nicotine treatment, brain slices were prepared and recordings were made from MHbVL and MHbVI neurons (Fig. 5A) . MHbVL neurons from mice treated with chronic nicotine displayed similar responses to puff-applied ACh (100 mM) compared with chronic saline control mice (saline: 520 6 140.1 pA, n 5 6; nicotine: 537 6 130.2 pA, n 5 7; p 5 0.8980; Fig. 5, B and C) . Conversely, chronic nicotine caused functional upregulation of nAChRs in MHbVI neurons; ACh-evoked inward currents were significantly enhanced by chronic nicotine treatment (saline: 439.5 6 43.1 pA, n 5 13; nicotine: 725.2 6 77.7 pA, n 5 15, p 5 0.0041; Fig. 5, B and D) .
Next, we sought to determine whether the functionally upregulated nAChRs in MHbVI neurons from mice treated chronically with nicotine are still resistant to desensitization similar to naïve MHbVI nAChRs (Fig. 3 ). Mice were implanted with minipumps delivering control saline or nicotine as described above. After 14 days, slices were prepared and whole-cell recordings were made from MHbVL and MHbVI neurons. ACh (100 mM) was puff applied before and after a bath application of 1 mM nicotine for 15 minutes. Recordings from MHbVL in both treatment groups displayed significant desensitization following 15 minutes of nicotine exposure (Fig.  6, A and B ; saline: 479.9 6 81.2 pA before acute nicotine and 239.0 6 37.2 pA after acute nicotine, n 5 7, p 5 0.0156; nicotine: 418.2 6 39.9 pA before acute nicotine and 245.3 6 37.3 pA after acute nicotine, n 5 9, p 5 0.0053). As with nAChRs in MHbVI neurons naïve to prior nicotine exposure, nAChRs in MHbVI neurons from mice treated chronically with saline or nicotine did not exhibit desensitization following an acute, bath application of nicotine (Fig. 6, A and B ; saline: 425.7 6 62.8 pA before acute nicotine and 398.3 6 69.5 pA after acute nicotine, n 5 8, p 5 0.4171; nicotine: 696.9 6 82.5 pA before acute nicotine and 579.9 6 60.6 pA after acute nicotine, n 5 11, p 5 0.1429).
Finally, we sought to identify the functional consequences of chronic nicotine treatment on neuronal activity in MHbVL and MHbVI. Experiments were performed as described in Fig.  5A . Cell-attached patch clamp recordings were made in MHbVL and MHbVI neurons from mice treated chronically with nicotine or saline for 14 days. Recordings in MHbVL neurons revealed that basal firing was indistinguishable between chronic nicotine-treated and chronic saline-treated groups (Fig. 7 , A and C; saline: 4.2 6 0.8 Hz, n 5 6; nicotine: 4.1 6 0.3 Hz, n 5 17; p 5 0.9359) and that bath application of acute nicotine (1 mM) resulted in a similar increase of firing frequency in both groups ( Fig. 7D ; saline: 2.0 6 0.2-fold increase, n 5 6; nicotine: 1.8 6 0.2-fold increase, n 5 6; p 5 0.4679). Also, the fold increase in MHbVL neuron action potential firing was the same as in untreated (no minipump implanted) mice (ANOVA: p 5 0.3461). Remarkably, MHbVI neurons from mice treated chronically with nicotine displayed a sustained elevation in their baseline firing rates relative to MHbVI neurons from mice treated chronically with saline (Fig. 7 , B and C; saline: 4.5 6 0.7 Hz, n 5 9; nicotine: 7.4 6 0.6 Hz, n 5 14; p 5 0.0064). In contrast to MHbVL neurons, when MHbVI neurons from mice treated chronically with nicotine were exposed to acute nicotine (1 mM), there was no additional gain in action potential firing compared with MHbVI neurons from mice treated chronically with saline ( Fig. 7D ; saline: 2.1 6 0.3-fold increase, n 5 6; nicotine: 1.1 6 0.1-fold increase, n 5 7; p 5 0.0188). Together, these results indicate that chronic nicotine selectively alters nAChR function and neuronal activity in different subregions of MHb.
Discussion
In this study, we sought to investigate subregions of MHb with regard to nAChR pharmacology and neuronal excitability using brain slice patch clamp electrophysiology. We determined that MHbVL and MHbVI subregions express pharmacologically distinct nAChRs. These distinct nAChRs respond differentially to both acute and chronic nicotine, and these differences directly translate into divergent action potential firing patterns in these MHb subregions.
Differential MHb nAChR Pharmacology. Our group and others have demonstrated high levels of a3 and b4 nAChR at ASPET Journals on November 3, 2015 molpharm.aspetjournals.org subunit expression and function in all areas of ventral MHb (Quick et al., 1999; Shih et al., 2014) . SR16584 antagonizes a3b4 nAChRs and has little activity at a4b2 and a7 nAChRs (Zaveri et al., 2010) . Thus, our data demonstrating that bathapplied SR16584 was effective at blocking ACh-evoked currents in both MHbVL and MHbVI are consistent with the prevailing notion that a3b4* nAChRs play a dominant role in mediating nicotinic cholinergic signaling in MHb (Quick et al., 1999) . Future pharmacological studies of SR16584s action at other nAChR subtypes will help confirm this suggestion. Although inward current responses attributed to MHbVL and MHbVI nAChRs were similar in overall sensitivity to puff-applied ACh (Fig. 1, C and D) , there was a differential sensitivity to DHbE (Fig. 1, G and H) . Although generally used to discriminate a7 from b2* nAChRs in native preparations, DHbE has moderate antagonist activity at uncommon nAChR subtypes that may be present in MHb. For example, experiments using human nAChRs expressed in Xenopus oocytes showed that DHbE is a potent antagonist at a2b2 and a4b4 nAChRs (Chavez-Noriega et al., 1997) . A wide array of nAChR subunits that are expressed in MHb cells, and responses evoked by 100 mM ACh are likely aggregate responses of multiple nAChR subtypes. Our DHbE data could reflect a slight sensitivity of multiple of these putative subtypes or it could reflect a complete block of a minor subtype and no antagonism of the others. More studies will be required to probe this question.
Our experiments (Fig. 2) utilizing aCtxMII, ACh applications, and a6L9S transgenic mice collectively support the idea that functional a6* nAChRs are expressed in MHbVI neurons, but are excluded from MHbVL neurons. These findings are in line with our previous study using mouse strains expressing green fluorescent protein-tagged a6 subunits, where a6 subunit immunoreactivity was demonstrated in MHbVI cells (Shih et al., 2014) . Our findings are similarly consistent with those of Henderson et al. (2014) , who also demonstrated a6 subunits in a subregion of MHb consistent with MHbVI.
Although nAChRs in MHbVL and MHbVI exhibited modest differences in response to acutely applied ACh, differences in their pharmacology was more pronounced when nicotine application was carried out. Nicotine-induced action potential firing was more rapid to reach the peak, but was attenuated in MHbVL cells. In contrast, firing developed more slowly and was more sustained in MHbVI cells (Fig. 3) . The ability of the same nicotine treatment protocol to preferentially desensitize nAChRs in MHbVL (Fig. 4) may account for the differences in action potential firing we observed. a3b4 nAChRs, although not especially sensitive to the desensitizing properties of nicotine (Fenster et al., 1997) , are expressed throughout the ventral MHb and therefore may not explain the difference we observe. Rather, a4 subunits in MHbVL may confer sensitivity to desensitization by nicotine, whereas the specific expression of a6 subunits in MHbVI may confer resistance to desensitization. This supposition is supported by our data, showing that MHbVL nAChRs lacking a4 subunits no longer desensitize in response to a 15-minute exposure to nicotine (Fig. 4, F and G). It is also supported by similar studies in VTA, another brain region expressing a4 and a6 subunits. Tapper et al. recently demonstrated that a6-expressing neurons in VTA exhibit more sustained firing when exposed to nicotine in the bath (Liu et al., 2012) . Marks et al. also demonstrated that a6 subunits confer resistance to desensitization by nicotine . It should be noted that these cited studies concern a4* and a6* nAChRs that assemble with b2 subunits. It is not yet clear whether b2 subunits play a role in the differential desensitization that we observe in MHb. b2 Subunits are expressed in most areas of ventral MHb and account for a substantial fraction of nAChRs in both the mouse and rat (Grady et al., 2009; Shih et al., 2014) .
Responses of MHb nAChRs and Neurons to Chronic Nicotine. In mice, chronic systemic nicotine treatment induces functional changes to nAChRs and/or neuronal circuits in the MHb to IPN pathway that is revealed by spontaneous or precipitated withdrawal approaches. Blockade of ongoing nicotinic cholinergic signaling in the MHb of mice chronically exposed to nicotine triggers withdrawal, and specific nAChR subtypes play a role in this response . Our goal was to further study this activity of nicotine, and we identified MHbVI as a specific site that undergoes functional upregulation of nAChR activity in response to chronic nicotine (Fig. 5) . These data are consistent with recent findings indicating that MHb a6 subunits, which are concentrated in MHbVI (Shih et al., 2014) , upregulate following chronic nicotine treatment (Henderson et al., 2014) . Conversely, we did not find nAChR activity to be functionally enhanced in MHbVL after chronic nicotine treatment (Fig. 5) . This result is consistent with previous work showing that a4 subunits, which are concentrated in MHbVL (Shih et al., 2014) , do not upregulate in response to chronic nicotine (Nashmi et al., 2007) . Indeed, after 24 hours of withdrawal from chronic nicotine, responses attributed to a4 subunits exhibit downregulation (Shih et al., 2014) . Although these data and observations from the literature suggest that a6 upregulates in the MHbVI in our experiments, further electrophysiology studies will be necessary to probe this question. This is particularly important given that our pharmacological experiments suggest that nAChRs containing a6 subunits are a minority, although of high sensitivity, subtype in MHbVI. These results demonstrate the importance of considering MHb subregions independently when studying nAChRs and chronic nicotine, as several recent studies did not identify changes in the response of MHb neurons to nicotine when the MHb was analyzed without considering subregions (Gorlich et al., 2013; Hsu et al., 2013; Dao et al., 2014) .
In addition to identifying changes in nAChR activity following chronic nicotine, we also connected these changes with alterations in action potential firing in MHb neurons exposed to nicotine. Chronic nicotine, but not chronic saline, caused an elevation in baseline action potential firing in MHbVI neurons (Fig. 7B ). Likely as a consequence of enhanced baseline firing/excitability, acute nicotine was no longer able to further increase firing in our experiments (Fig.  7D) . Thus, we have identified a specific neuron type that exhibits tolerance to acute nicotine exposure as a result of prior chronic exposure to nicotine. If our slice experiments are representative of MHbVI firing patterns in vivo, these data describe a potentially important change in MHb/IPN pathway circuit activity. Our recent data describing nAChR subunit expression/localization in the MHb/IPN pathway (Shih et al., 2014) confirm what was previously seen in anatomic studies (Contestabile and Flumerfelt, 1981) : MHbVI projects to ventral IPN areas, whereas MHbVL projects more preferentially to dorsal IPN. It has recently become apparent that dorsal IPN neurons control somatic withdrawal responses (Zhao-Shea et al., 2013) , and ventral IPN neurons control affective responses (Zhao-Shea et al., 2015) . Moreover, during precipitated withdrawal from chronic nicotine exposure, MHb-derived inputs onto ventral IPN neurons control anxiety responses (Zhao-Shea et al., 2015) . In our study, enhanced baseline firing and reduced nicotine-elicited firing in MHbVI neurons chronically exposed to nicotine is likely involved in activation of this affective withdrawal circuit in ventral IPN. Exerting specific control over MHbVI nAChRs and/or neuronal activity could be useful in modulating anxiety during nicotine withdrawal/cessation in human tobacco users.
Conclusion and Impact. The data we present here advance our knowledge of a key brain circuit involved in human nicotine intake, and future studies in rats or nonhuman primates should test our present conclusions in mouse models. We have shown previously (Shih et al., 2014) and in this study that MHb neurons and nAChRs are diverse in their pharmacology and activity patterns/excitability, respectively. As such, future mechanistic studies on the role of the MHb in nicotine addiction/withdrawal should discriminate between the various subregions that exist within the MHb. Because these different MHb subregions are known to project to different areas of IPN, and because these different areas of IPN mediate different aspects of nicotine withdrawal, these results may lead to a better understanding of nicotine dependence.
